Freshfields has advised Biotronik Group on an agreement to divest its Vascular Intervention division to Teleflex Incorporated.
The transaction remains contingent on regulatory approvals.
Biotronik Group is a medical technology company based in Berlin.
Teleflex Incorporated is a medical technology provider.
The Freshfields team included Vienna-based Counsel Lukas Pomaroli as well as further lawyers in Frankfurt, Berlin, Hamburg, Duesseldorf, Munich, Amsterdam, Paris, Brussels, Ho Chi Minh City, Hong Kong, Madrid, Milan, New York City, Shanghai, Tokyo, and Washington.
Freshfields did not respond to our inquiry on the matter.